F-star Therapeutics, Inc.
FSTXDelisted Mar 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566373
F-star Therapeutics, Inc. was delisted on Mar 9, 2023; its insiders filed their last Form 4 on Mar 9, 2023; 59 institutions reported holding it in 13F filings for Q4 2022, worth $57.8M in total; Fairfax Financial was the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in F-star Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −3 vs. Q4 2021
- Shares held
- 8.18M
- −2.42M (−22.9%) vs. Q4 2021
- Total value
- $29.0M
- −$24.2M (−45.5%) vs. Q4 2021
- New holders
- 7
- 9 more added
- Sold out
- 10
- 11 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FSTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 59 | $57.8M |
| Q3 2022 | 54 | $35.5M |
| Q2 2022 | 53 | $45.1M |
| Q1 2022 | 40 | $29.0M |
| Q4 2021 | 43 | $53.2M |
| Q3 2021 | 37 | $71.9M |
| Q2 2021 | 41 | $93.5M |
| Q1 2021 | 26 | $19.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding F-star Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 900,000 | $3.19M | 0.01% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 850,000 | $3.02M | 0.01% | −131,249−13.4% | Reduced |
| Price T Rowe Associates Inc | 789,590 | $2.80M | 0.00% | −68,505−8.0% | Reduced |
| Rock Springs Capital Management LP | 751,889 | $2.67M | 0.07% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 693,785 | $2.46M | 0.64% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 601,394 | $2.13M | 0.00% | +356,317+145.4% | Added |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $2.13M | 0.27% | 00.0% | Unchanged |
| Vanguard Group Inc | 598,437 | $2.12M | 0.00% | −149,263−20.0% | Reduced |
| Atlas Venture Advisors, Inc. | 574,996 | $2.04M | 0.44% | 00.0% | Unchanged |
| BlackRock Inc. | 295,947 | $1.05M | 0.00% | +4,776+1.6% | Added |
| Citadel Advisors LLC | 292,993 | $1.04M | 0.00% | +18,893+6.9% | Added |
| Renaissance Technologies LLC | 249,140 | $884.0K | 0.00% | −40,271−13.9% | Reduced |
| Anson Funds Management LP | 185,261 | $658.0K | 0.09% | −124,442−40.2% | Reduced |
| Geode Capital Management, LLC | 145,431 | $516.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 85,834 | $305.0K | 0.00% | +40,514+89.4% | Added |
| Barclays PLC | 75,190 | $267.0K | 0.00% | +75,190 | New |
| TD Asset Management Inc | 58,487 | $208.0K | 0.00% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 54,981 | $194.4K | 0.00% | +54,981 | New |
| State Street Corp | 53,150 | $189.0K | 0.00% | +7,180+15.6% | Added |
| Connolly Sarah T. | 53,001 | $188.0K | 0.11% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 45,752 | $163.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 35,102 | $125.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 33,802 | $120.0K | 0.00% | +33,802 | New |
| Parsons Capital Management Inc | 21,291 | $76.0K | 0.01% | −588−2.7% | Reduced |
| JPMorgan Chase & Co | 21,335 | $76.0K | 0.00% | +12,891+152.7% | Added |
| Morgan Stanley | 18,041 | $64.0K | 0.00% | −808−4.3% | Reduced |
| D. E. Shaw & Co., Inc. | 15,865 | $56.0K | 0.00% | +15,865 | New |
| Envestnet Asset Management Inc | 13,564 | $48.0K | 0.00% | +13,564 | New |
| Private Capital Advisors, Inc. | 13,083 | $46.0K | 0.01% | 00.0% | Unchanged |
| Silvercrest Asset Management Group LLC | 12,585 | $45.0K | 0.00% | 00.0% | Unchanged |
| Jump Financial, LLC | 11,300 | $40.0K | 0.00% | −13,100−53.7% | Reduced |
| Marshall Wace, LLP | 10,456 | $37.0K | 0.00% | +10,456 | New |
| Bryn Mawr Trust Co | 10,000 | $36.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 4,327 | $15.0K | 0.00% | +3,278+312.5% | Added |
| Tower Research Capital LLC (TRC) | 3,065 | $11.0K | 0.00% | −7,680−71.5% | Reduced |
| TCI Wealth Advisors, Inc. | 300 | $1.00K | 0.00% | +100+50.0% | Added |
| Bank of America Corp | 162 | $1.00K | 0.00% | +162 | New |
| Cubist Systematic Strategies, LLC | 66 | $0 | 0.00% | −5,796−98.9% | Reduced |
| Wells Fargo & Company | 117 | $0 | 0.00% | +1+0.9% | Added |
| UBS Group AG | 50 | $0 | 0.00% | −189−79.1% | Reduced |
| Ridgeback Capital Investments L.P. | 0 | $0 | 0.00% | −1,834,360−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −522,158−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −79,092−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −49,933−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −14,251−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −10,700−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −10,854−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Arcadia Investment Management Corp | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,366−100.0% | Sold out |